Next, BRAF-600 in SKCM was observed in 141 samples, followed by KRAS-12 in PAAD, identified in 128 samples; GNAQ-209 in UVM, found in 37 samples; FGFR3-249 in BLCA, seen in 29 samples; PPP2R1A-179 in UCEC, present in 26 samples; AKT1-17 in BRCA, noted in 24 samples; EGFR-858 in LUAD, seen in 21 samples; and IDH2-172 in LGG, identified in 20 samples. This evidence concerns the gene KRAS and bladder transitional cell carcinoma.